Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient

Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increasing incidence and mortality. While most patients can be treated successfully with surgical excision, cryotherapy, or radiation therapy, there exist a subset of patients with aggres...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Dejan Vidovic, Gordon A. Simms, Sylvia Pasternak, Mark Walsh, Kevork Peltekian, John Stein, Lucy K. Helyer, Carman A. Giacomantonio
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2021-05-01
Edice:	Frontiers in Immunology
Témata:	intralesional immunotherapy intralesional IL-2 organ transplant recipient imiquimod cutaneous squamous cell carcinoma (cSCC) intralesional
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.678028/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!